최신 재무제표(Form-10K)에 따르면, Avantor Inc의 총 자산은 $0이며, 순손실입니다.
AVTR의 주요 재무 비율은 무엇인가요?
Avantor Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Avantor Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Avantor Inc 주요 수익원은 Laboratory Solutions이며, 최신 수익 발표에서 수익은 4,399,700,000입니다. 지역별로는 Americas이 Avantor Inc의 주요 시장이며, 수익은 4,071,600,000입니다.
Avantor Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Avantor Inc의 순손실은 $0입니다.
Avantor Inc에 부채가 있나요?
no, Avantor Inc의 부채는 0입니다.
Avantor Inc의 발행 주식은 몇 주인가요?
Avantor Inc의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$7.94
시가
$7.92
일일 범위
$7.61 - $8.01
52주 범위
$7.26 - $15.93
거래량
7.9M
평균 거래량
10.9M
배당수익률
0.00%
EPS(TTM)
-0.81
시가총액
$5.1B
AVTR란 무엇인가요?
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.